Choosing the Appropriate Treatment for Metastatic Uveal Melanoma

EP: 1.Brief Overview of Uveal Melanoma

EP: 2.A Cure in Sight: Who We Are

EP: 3.Diagnosing Uveal Melanoma

EP: 4.Resources for Patients With Newly Diagnosed Uveal Melanoma

EP: 5.Uveal Melanoma Prognosis and Risk Stratification

Now Viewing

EP: 6.Choosing the Appropriate Treatment for Metastatic Uveal Melanoma

EP: 7.Safety and Efficacy of Tebentafusp

EP: 8.Unmet Needs and Challenges in Metastatic Uveal Melanoma

Video content above is prompted by the following:

• Provide a brief overview of the current guidelines for the treatment of metastatic uveal melanoma.
• How has the approval of tebentafusp impacted the treatment landscape?
• How do you determine the right treatment for each patient?
• Provide a brief overview of the mechanism of action of tebentafusp. Which patients are eligible for this treatment? 
• Why is it important for patients to know if they are HLA-A*02:01 positive?
• For patients not eligible for tebentafusp, what are your recommendations?
• As an advocate, how would you advise patients on how to approach selecting the best treatment option?
• What factors impact patients’ treatment selection, and what barriers do they face when selecting a treatment?
• How do you encourage patients to advocate for themselves when making decisions for their treatment? 
• General query for these questions: Should they say the patient would work with their doctor to select best treatment for their situation?